Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

54.29
+0.67001.25%
Post-market: 54.00-0.2900-0.53%19:30 EDT
Volume:1.65M
Turnover:89.37M
Market Cap:8.31B
PE:19.61
High:54.98
Open:54.17
Low:53.15
Close:53.62
52wk High:59.30
52wk Low:26.76
Shares:153.09M
Float Shares:141.54M
Volume Ratio:0.98
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):2.77
ROE:100.28%
ROA:7.28%
PB:13.76
PE(LYR):19.60

Loading ...

OverviewCompanyNewsFilings

TG Therapeutics Q1 EPS USD 0.12

THOMSON REUTERS
·
May 06

Precision Bio Q1 sales beat, helped by milestone revenue

Reuters
·
May 05

TG Therapeutics Inc expected to post earnings of 30 cents a share - Earnings Preview

Reuters
·
May 04

TG Therapeutics announces annual shareholder meeting via webcast

Reuters
·
May 01

TG Therapeutics to host conference call on first-quarter results and 2026 outlook

Reuters
·
Apr 30

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting

GlobeNewswire
·
Apr 22

Goldman Sachs Reaffirms Their Hold Rating on TG Therapeutics (TGTX)

TIPRANKS
·
Apr 16

TG Therapeutics completes enrollment in Phase 3 subcutaneous Briumvi trial in MS

Reuters
·
Apr 15

TG Therapeutics Inc - Top-Line Data From Phase 3 Subcutaneous Briumvi Trial Expected Year-End 2026 or Q1 2027

THOMSON REUTERS
·
Apr 15

Analysts Conflicted on These Healthcare Names: TG Therapeutics (TGTX), Insmed (INSM) and Solventum Corporation (SOLV)

TIPRANKS
·
Apr 08

Analyst Rate

Buy
Buy
87.50%
Hold
0.00%
Sell
12.50%

Corporate Actions

Financial Report Announcement
Aug 03, 2026 Pre-MKt
Financial Report Announcement
May 06, 2026 Pre-MKt
Financial Report Announcement
Feb 26, 2026 Pre-MKt
Financial Report Announcement
Jan 13, 2026 Post-Mkt
Financial Report Announcement
Nov 03, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

19.61
Current
4.92
Sector Average
69.84%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
19.61
Maximum
294.97
+1 STD
112.30
Minimum
-350.41
-1 STD
-102.46
Average
4.92

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.